The Health Sciences Institute is intended to provide cutting-edge health information.
Nothing on this site should be interpreted as personal medical advice. Always consult with your doctor before changing anything related to your healthcare.

Vioxx osteoarthritis pain

A lot to imagine

The advertisements for Vioxx encourage you to “imagine planning your day around your life, instead of your osteoarthritis pain.” For the millions of people who regularly suffer with that pain, it’s certainly an appealing thought. But according to a new report, at least five Vioxx users found themselves putting their lives on hold instead – because the drug caused a life-threatening side effect. In this week’s issue of the Archives of Internal Medicine, doctors from the Food and Drug Administration detail five cases of aseptic meningitis that are believed to be associated with the use of rofecoxib (Vioxx). The victims ranged in age from 16 to 67, all developed symptoms within as little as 12 days on the drug – and all ended up hospitalized with this life-threatening disease.
Dangerous NSAID side effect also applies to COX-2 inhibitors

When most people use the term “meningitis,” they actually mean bacterial meningitis. But in this case, we’re talking about aseptic meningitis, which is not caused by bacteria. Like the more common bacterial variety, aseptic meningitis is characterized by inflammation of the brain and spinal cord. It can be caused by a virus – and, according to the report, it’s a known rare side effect of other non-steroidal anti-inflammatory drugs (NSAIDs), like ibuprofen, tolmetin sodium (Tolectin), sulindac (Clinoril), and naproxen (Aleve, Naprosyn).

Vioxx (also known by its generic name rofecoxib) is one of a new class of NSAIDs called COX-2 inhibitors. They were designed to relieve pain without causing the gastrointestinal side effects that often accompany traditional NSAIDs. But they haven’t been without their problems. In the October 8, 2001 e-Alert we told you about how Vioxx might increase your risk of a heart attack. And in the January 2, 2002 e-Alert, we revealed how Vioxx and other COX-2 inhibitors like Celebrex can cause reduced kidney function in elderly patients and diabetics.

Although aseptic meningitis has been listed as a possible side effect on Vioxx’s product label and package insert since 2000, until recently, there were no cases documented in the medical literature. We should note that the FDA report doesn’t say that Vioxx directly caused these cases.

But I think the evidence speaks for itself. All of the patients in the report developed symptoms like headache, neck stiffness, eye pain, fever, confusion, and weakness within days of beginning Vioxx therapy. All were hospitalized, and all improved after being taken off a Vioxx. In one case, Vioxx was re-introduced twice after the initial recovery, and both times symptoms reappeared. The report also notes that there were two other cases that were not included because of complete information. And an Associated Press story reported that there are at least another six cases of meningitis that have been linked to Celebrex, another COX-2 inhibitor.
It’s a roll of the dice – no clear cut way to assess your risk

Granted, the numbers are small; Merck was quick to point out that 52 million prescriptions for Vioxx have been written since the drug was approved in 1999. But it’s important to note that the patients in this report didn’t share many similarities, other than their Vioxx use. Four of the five were women, and the report suggests that aseptic meningitis occurs more often in women. But aside from that, it’s impossible to say who might be more susceptible to this side effect than others.

If you take Vioxx or Celebrex, pay close attention to any unusual symptoms you may develop. If you get a severe headache, a stiff neck, an unexplained fever, or any of the other symptoms I detailed above, see your doctor immediately. Make sure that any health care professional who treats you knows the drugs that you take – and make sure they know about the possible connection.

And the March issue of your Members’ Alert told you about Nexrutine, a proprietary discovery from Next Pharmaceuticals, that was showing great promise in easing joint pain and other symptoms. To read the March article, follow this link: http://www.hsionline.com/hsi_0203_a.shtml

Everyone deserves the opportunity to live without arthritis pain. But none of us wants to trade that pain for another health problem – especially one that could land you in the hospital. Make sure you have all the facts before you decide how to treat your pain – and please be sure you report any usual changes to your doctor immediately.

Source: Archives of Internal Medicine 2002;162:713-715

Copyright 1997-2002 by Institute of Health Sciences, L.L.C.

Get a free copy of 5 Household Items that Cause Cancer

By texting HSI to 844-539-1128, you are providing your electronic signature expressly consenting to be called and texted (including by prerecorded messages, using an autodialer, and/or automated means) with alerts, stories, reports, and marketing communications from Institute of Health Sciences, LLC. and its authorized representatives at the phone number you provide, including landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also consent and unconditionally agree to our Privacy Policy and Terms of Use, including the arbitration provision and class action waiver contained therein. Msg&data rates may apply. 15 Msgs/Month. You are not required to agree to this as a condition of making a purchase.

Terms & Conditions

The following Terms and Conditions apply to your use of the website located at hsionline.com (the “website”) and any text messages that you send to or receive from the Institute of Health Sciences, L.L.C. These Terms and Conditions constitute a binding agreement (“Agreement”) between you (“you”) Institute of Health Sciences, L.L.C (“we”, “us”, etc.)  Please read these terms carefully. 

By providing your telephone number to us, texting us a short code listed on the website, or otherwise indicate your agreement to these Terms and Conditions, you are agreeing to the mandatory arbitration provision and class action waiver below. 

ARBITRATION IS MANDATORY AND THE EXCLUSIVE REMEDY FOR ANY AND ALL DISPUTES RELATED TO THIS WEBSITE, THIS AGREEMENT, AND ANY TELEPHONE CALLS, EMAILS, OR TEXT MESSAGES THAT YOU RECEIVE FROM OR ON BEHALF OF US, UNLESS SPECIFIED BELOW OR UNLESS YOU OPT-OUT.

Text Messaging and Telemarketing Terms and Conditions

When you provide your telephone number on this website or send a text message to us with or from a short-code, you agree to receive alerts and communications, and marketing messages including those sent via automated telephone dialing system, text messages, SMS, MMS, and picture messages from Institute of Health Sciences, L.L.C at the phone number you provide on this website or the phone number from which you text the short code, including on landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also agree to the mandatory arbitration provision and class action waiver below. Your consent is not required to purchase goods or services. Message & data rates may apply.

You may opt-out at any time by texting the word STOP to the telephone number from which you receive the text messages.  Call 1-888-213-0764 to learn more.  By providing your telephone number, you agree to notify us of any changes to your telephone number and update your account us to reflect this change. Your carrier may charge you for text messages and telephone calls that you receive, or may prohibit or restrict certain mobile features, and certain mobile features may be incompatible with your carrier or mobile device. Contact your carrier with questions regarding these issues.

Dispute Resolution by Binding Arbitration and Class Action Waiver

Any dispute relating in any way to telephone calls, emails, or text messages that you receive from or on behalf of Institute of Health Sciences, L.L.C this website, or this Agreement (collectively “Disputes”) shall be submitted to confidential arbitration and shall be governed exclusively by the laws of the State of Maryland, excluding its conflict of law provisions.  For the avoidance of doubt, all claims arising under the Telephone Consumer Protection Act and state telemarketing laws shall be considered “Disputes” that are subject to resolution by binding individual, confidential arbitration.

If a Dispute arises under this Agreement, you agree to first contact us at 1-888-213-0764 or help@hsionline.com. Before formally submitting a Dispute to arbitration, you and we may choose to informally resolve the Dispute.  If any Dispute cannot be resolved informally, you agree that any and all Disputes, including the validity of this arbitration clause and class action waiver, shall be submitted to final and binding arbitration before a single arbitrator of the American Arbitration Association (“AAA”) in a location convenient to you or telephonically. Either you or we may commence the arbitration process by submitting a written demand for arbitration with the AAA, and providing a copy to the other party.  The arbitration will be conducted in accordance with the provisions of the AAA’s Commercial Dispute Resolutions Procedures, Supplementary Procedures for Consumer-Related Disputes, in effect at the time of submission of the demand for arbitration.  Except as may be required by law as determined by the arbitrator, no party or arbitrator may disclose the existence, content or results of any arbitration hereunder without the prior written consent of both parties. Institute of Health Sciences, L.L.C will pay all of the filing costs.  Without limiting the foregoing, YOU EXPRESSLY AGREE TO SUBMIT TO ARBITRATION ALL DISPUTES RELATING TO ANY TEXT MESSAGES OR TELEPHONE CALLS YOU RECEIVE FROM OR ON BEHALF OF US OR ANY ENTITY WITH WHOM WE MAY SHARE YOUR TELEPHONE NUMBER.  Further, we both agree that all entities with whom we share your telephone numbers shall be third party beneficiaries of this Agreement to Arbitrate Disputes, and that those entities have the same rights as Institute of Health Sciences, L.L.C to enforce this arbitration provision.

Notwithstanding the foregoing, the following shall not be subject to arbitration and may be adjudicated only in the state and federal courts of Maryland: (i) any dispute, controversy, or claim relating to or contesting the validity of our or one of our family company’s intellectual property rights and proprietary rights, including without limitation, patents, trademarks, service marks, copyrights, or trade secrets; (ii) an action by us for temporary or preliminary injunctive relief, whether prohibitive or mandatory, or other provisional relief; (iii) any legal action by us against a non-consumer; or (iv) interactions with governmental and regulatory authorities.  You expressly agree to refrain from bringing or joining any claims in any representative or class-wide capacity, including but not limited to bringing or joining any claims in any class action or any class-wide arbitration.

The arbitrator’s award shall be binding and may be entered as a judgment in any court of competent jurisdiction. To the fullest extent permitted by applicable law, no arbitration under this Agreement may be joined to an arbitration involving any other party subject to this Agreement, whether through a class action, private attorney general proceeding, class arbitration proceedings or otherwise.

YOU UNDERSTAND THAT YOU WOULD HAVE HAD A RIGHT TO LITIGATE IN A COURT, TO HAVE A JUDGE OR JURY DECIDE YOUR CASE AND TO BE PARTY TO A CLASS OR REPRESENTATIVE ACTION.  HOWEVER, YOU UNDERSTAND AND AGREE TO HAVE ANY CLAIMS DECIDED INDIVIDUALLY AND ONLY THROUGH ARBITRATION.  You shall have thirty (30) days from the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, to opt out of this arbitration agreement, by contacting us by email at help@hsionline.com or by mail Health Sciences Institute, PO Box 913, Frederick, MD 21705-0913. If you do not opt out by the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, then you are not eligible to opt out of this arbitration agreement.

Electronic Signatures

All information communicated on the website is considered an electronic communication.  When you communicate with us through or on the website, by text message or telephone, or via other forms of electronic media, such as e-mail, you are communicating with us electronically.  You agree that we may communicate electronically with you and that such communications, as well as notices, disclosures, agreements, and other communications that we provide to you electronically, are equivalent to communications in writing and shall have the same force and effect as if they were in writing and signed by the party sending the communication.

You further acknowledge and agree that by clicking on a button labeled “ORDER NOW”, “SUBMIT”, “I ACCEPT”, “I AGREE”, “YES”, by texting a short code to us in response to a request on this website, or by clicking or similar links or buttons, you are submitting a legally binding electronic signature and are entering into a legally binding contract.  You acknowledge that your electronic submissions constitute your agreement and intent to be bound by this Agreement.  Pursuant to any applicable statutes, regulations, rules, ordinances or other laws, including without limitation the United States Electronic Signatures in Global and National Commerce Act, P.L. 106-229 (the “E-Sign Act”) or other similar statutes, YOU HEREBY AGREE TO THE USE OF ELECTRONIC SIGNATURES, CONTRACTS, ORDERS AND OTHER RECORDS AND TO ELECTRONIC DELIVERY OF NOTICES, POLICIES AND RECORDS OF TRANSACTIONS INITIATED OR COMPLETED THROUGH THE WEBSITE.  Furthermore, you hereby waive any rights or requirements under any statutes, regulations, rules, ordinances or other laws in any jurisdiction which require an original signature, delivery or retention of non-electronic records, or to payments or the granting of credits by other than electronic means You may receive a physical paper copy of this contract by contacting us at help@hsionline.com.

Privacy Policy

Please read our Privacy Policy, which is incorporated herein by reference.  In the event of any conflict between these Terms and Conditions and the Privacy Policy, these Terms shall control.

Contact Us

You may contact us by telephone at 1-888-213-0764 or by email at help@hsionline.com.